Benign neoplasm: Endocrine pancreas

pancreatic neuroendocrine tumor: Pancreatic endocrine tumor, also known as pancreatic neuroendocrine tumor (PNET), describes a group of endocrine tumors originating in the pancreas that are usually indolent and benign, but may have the potential to be malignant. They can be functional, exhibiting a hormonal hypersecretion syndrome, but can be non-functional presenting with non-specific symptoms and include insulinoma, glucagonoma, VIPoma, somatostatinoma (SSoma), PPoma and Zollinger-Ellison syndrome (ZES, or gastrinoma) and other ectopic hormone producing tumors (such as GRFoma) (see these terms).

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries Inpat., Oupat., Death

Hospital Discharge: ICD-10 D13.7&
Hospital discharge: ICD-9 2117
Cause of death: ICD-10 D13.7&
Cause of death: ICD-9 2117

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector CD2_BENIGN_ENDOCRINE_PANCREAS

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D13
Name in latin Neoplasma benignum partis endocrinae pancreatis

Summary Statistics

Key figures

All Female Male
Number of individuals 73 30 43
Unadjusted prevalence (%) 0.03 0.02 0.04
Mean age at first event (years) 60.18 54.50 64.14

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

Index endpoint: CD2_BENIGN_ENDOCRINE_PANCREAS – Benign neoplasm: Endocrine pancreas
GWS hits:

Survival analyses between endpoints

Plot

before Benign neoplasm: Endocrine pancreas
after Benign neoplasm: Endocrine pancreas

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Benign neoplasm: Endocrine pancreas